Strata Skin Sciences, Inc. SSKN
0.01
0.00
0.00%
as of 25 Sep
- Market cap
- $1.0M
- P/E
- 0.0×
Follow SSKN
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Sep '25 | Jun '25 | Mar '25 | Older periods | |
|---|---|---|---|---|---|
| (158.91%) | (208.09%) | (235.41%) | (151.23%) |
+8 more TTM periods Free account |
|
| (19.13%) | (31.27%) | (32.83%) | (24.63%) | ||
ROIC |
(28.40%) | (63.41%) | (65.80%) | (52.10%) | |
Return on Tangible Assets |
287.60% | (126.06%) | (137.81%) | (89.71%) | |
Average Days of Receivables |
49.00 | 41.28 | 44.69 | 54.36 | |
Free Cash Flow per Share |
(0.92) | (0.78) | (0.67) | (0.16) | |
Free Cash Flow |
(4.26) | (3.51) | (2.79) | (0.67) | |
Capital Expenditures |
(1.47) | (1.66) | (0.70) | (1.11) | |
Piotroski F-Score |
4.00 | 3.00 | 3.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(10.68%) | (7.81%) | (9.70%) | 1.72% | |
Accounts Receivable Turnover |
6.55 | 7.80 | 8.21 | 7.79 | |
Accounts Payable Turnover |
4.94 | 5.51 | 4.71 | 4.32 | |
Inventory Turnover |
5.07 | 4.47 | 4.63 | 5.17 | |
Average Days of Payables |
78.55 | 83.20 | 78.29 | 74.31 | |
Days of Inventory on Hand |
80.15 | 86.10 | 86.03 | 70.17 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1.37% | 1.79% | 1.90% | 2.20% | |
Selling, General and Administrative Expense of Revenue |
75.89% | 76.07% | 74.11% | 68.90% | |
Share Based Compensation of Revenue |
2.09% | 1.92% | 1.25% | 1.32% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.45 | 0.17 | 0.18 | (0.05) | |
Depreciation/Fixed assets |
0.52 | 0.53 | 0.63 | 0.57 | |
Capex/Depreciation |
(0.32) | (0.33) | (0.13) | (0.20) | |
Revenue per Share |
6.60 | 6.91 | 7.88 | 8.06 | |
Operating CF per Share |
(0.60) | (0.41) | (0.50) | 0.11 | |
Capex per Share |
(0.32) | (0.37) | (0.17) | (0.27) | |
Capex to Sales |
0.05 | 0.05 | 0.02 | 0.03 | |
Net Profit Margin |
(20.40%) | (35.79%) | (35.13%) | (27.22%) |
Columns are period end dates